Effect of linezolid and teicoplanin on skin staphylococci

被引：2
|
作者：
Hayman, Samantha
Wilson, A. Peter R.
Singer, Mervyn
Bellingan, Geoffrey
机构：
[1] UCL Hosp, Dept Clin Microbiol, London W1T 4JF, England
[2] UCL, Bloomsbury Inst Intens Care Med, Dept Med, London WC1E 6BT, England
[3] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2007年 / 59卷 / 06期
关键词：
glycopeptides; oxazolidinones; MRSA;
D O I：
10.1093/jac/dkm093
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1281 / 1282
页数：2
相关论文
共 50 条
  • [21] Screening method for detecting staphylococci with reduced susceptibility to teicoplanin
    Park, YJ
    Kim, M
    Oh, EJ
    Lee, SO
    Kim, BK
    Kim, SM
    JOURNAL OF MICROBIOLOGICAL METHODS, 2000, 40 (02) : 193 - 198
  • [22] The emergence of Staphylococcus epidermidis simultaneously nonsusceptible to linezolid and teicoplanin in China
    Liu, Cailin
    Chen, Chunguang
    Ye, Yafei
    Li, Xiaogai
    Sun, Jingjing
    Xu, Lijuan
    Ming, Liang
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2020, 96 (02)
  • [23] Linezolid Therapy of Bloodborne Teicoplanin-Resistant Staphylococcus haemolyticus
    I. Mohammedi
    S. Malhière
    D. Robert
    M. A. Charveriat
    J. Etienne
    Infection, 2006, 34 : 292 - 293
  • [24] SEPTICEMIA AND SKIN INFECTIONS IN BURNT PATIENTS TREATED BY TEICOPLANIN - STUDY OF TEICOPLANIN DIFFUSION IN SKIN
    RIO, Y
    GIORGI, C
    SCHOCKMEL, G
    DIDION, J
    JURIN, F
    MELEY, M
    TARRAL, A
    PATHOLOGIE BIOLOGIE, 1987, 35 (05): : 603 - 607
  • [25] What is the place of teicoplanin and linezolid in the treatment of prosthetic joint infections?
    Tattevin, P.
    Arvieux, C.
    Michelet, C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (12) : 1241 - 1242
  • [26] Linezolid therapy of bloodborne teicoplanin-resistant Staphylococcus haemolyticus
    Mohammedi, I.
    Malhiere, S.
    Charveriat, M. A.
    Robert, D.
    Etienne, J.
    INFECTION, 2006, 34 (05) : 292 - 293
  • [27] Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci
    Betriu, C
    Redondo, M
    Boloix, A
    Gómez, M
    Culebras, E
    Picazo, JJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (06) : 911 - 913
  • [28] Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin
    Shiraishi, Y.
    Okajima, M.
    Sai, Y.
    Miyamoto, K.
    Inaba, H.
    ANAESTHESIA AND INTENSIVE CARE, 2012, 40 (03) : 442 - 449
  • [29] In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients
    Wilson, A. Peter R.
    Cepeda, Jorge A.
    Hayman, Samantha
    Whitehouse, Tony
    Singer, Mervyn
    Bellingan, Geoffrey
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (02) : 470 - 473
  • [30] Comment on: Linezolid resistance in coagulase-negative staphylococci
    Jones, Ronald N.
    Ross, James E.
    Fritsche, Thomas R.
    Sader, Helio S.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (04) : 899 - 900
12345